DACARBAZINE Drug Patent Profile
✉ Email this page to a colleague
When do Dacarbazine patents expire, and what generic alternatives are available?
Dacarbazine is a drug marketed by Abraxis Pharm, Fresenius Kabi Usa, Hikma, Hospira, and Meitheal. and is included in six NDAs.
The generic ingredient in DACARBAZINE is dacarbazine. There are nine drug master file entries for this compound. Four suppliers are listed for this compound. Additional details are available on the dacarbazine profile page.
DrugPatentWatch® Litigation and Generic Entry Outlook for Dacarbazine
A generic version of DACARBAZINE was approved as dacarbazine by MEITHEAL on August 27th, 1998.
Summary for DACARBAZINE
US Patents: | 0 |
Applicants: | 5 |
NDAs: | 6 |
Finished Product Suppliers / Packagers: | 4 |
Raw Ingredient (Bulk) Api Vendors: | 80 |
Clinical Trials: | 235 |
Patent Applications: | 5,725 |
Formulation / Manufacturing: | see details |
Drug Prices: | Drug price information for DACARBAZINE |
DailyMed Link: | DACARBAZINE at DailyMed |
Recent Clinical Trials for DACARBAZINE
Identify potential brand extensions & 505(b)(2) entrants
Sponsor | Phase |
---|---|
Guangzhou Gloria Biosciences Co., Ltd. | Phase 2 |
University College, London | Phase 2 |
Chung Mei Biopharma Co., Ltd | Phase 1/Phase 2 |
Pharmacology for DACARBAZINE
Drug Class | Alkylating Drug |
Mechanism of Action | Alkylating Activity |
Medical Subject Heading (MeSH) Categories for DACARBAZINE
Anatomical Therapeutic Chemical (ATC) Classes for DACARBAZINE
US Patents and Regulatory Information for DACARBAZINE
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Abraxis Pharm | DACARBAZINE | dacarbazine | INJECTABLE;INJECTION | 070962-001 | Aug 28, 1986 | DISCN | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | ||||
Hospira | DACARBAZINE | dacarbazine | INJECTABLE;INJECTION | 075940-001 | Oct 18, 2001 | AP | RX | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | |||
Fresenius Kabi Usa | DACARBAZINE | dacarbazine | INJECTABLE;INJECTION | 075371-002 | Aug 27, 1999 | AP | RX | No | Yes | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | |||
Meitheal | DACARBAZINE | dacarbazine | INJECTABLE;INJECTION | 075259-002 | Aug 27, 1998 | AP | RX | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | |||
Abraxis Pharm | DACARBAZINE | dacarbazine | INJECTABLE;INJECTION | 070990-001 | Aug 28, 1986 | DISCN | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | ||||
Fresenius Kabi Usa | DACARBAZINE | dacarbazine | INJECTABLE;INJECTION | 075371-001 | Aug 27, 1999 | RX | No | Yes | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | ||||
Hikma | DACARBAZINE | dacarbazine | INJECTABLE;INJECTION | 075812-002 | Oct 31, 2002 | AP | RX | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | |||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |